Ghai RD - Search Results

1

Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney.

Sonnenberg JL, Sakane Y, Jeng AY, Koehn JA, Ansell JA, Wennogle LP, Ghai RD. Sonnenberg JL, et al. Among authors: ghai rd. Peptides. 1988 Jan-Feb;9(1):173-80. doi: 10.1016/0196-9781(88)90024-1. Peptides. 1988. PMID: 2966343

2

The biological activity of atrial natriuretic factor cleaved by endoprotease 3.4.24.11.

Ghai RD, Webb RL, Sonnenberg JL, Sakane Y, Ghai G. Ghai RD, et al. Among authors: ghai g. J Enzyme Inhib. 1991;4(3):267-72. doi: 10.3109/14756369109035850. J Enzyme Inhib. 1991. PMID: 1645400

3

Characterisation of neutral endopeptidase 3.4.24.11 (NEP) in the kidney: comparison between normotensive, genetically hypertensive and experimentally hypertensive rats.

Schulz R, Sakane Y, Berry C, Ghai R. Schulz R, et al. J Enzyme Inhib. 1991;4(4):347-58. doi: 10.3109/14756369109030399. J Enzyme Inhib. 1991. PMID: 1669834

4

Degradation of atrial natriuretic factor by kidney cortex membranes. Isolation and characterization of the primary proteolytic product.

Koehn JA, Norman JA, Jones BN, LeSueur L, Sakane Y, Ghai RD. Koehn JA, et al. Among authors: ghai rd. J Biol Chem. 1987 Aug 25;262(24):11623-7. J Biol Chem. 1987. PMID: 2957371 Free article.

5

A rapid indirect method to determine the plasma concentrations of neutral endopeptidase inhibitors.

Ghai RD, De Lombaert S, Ksander GM, Berry C, Sakane Y, Trapani AJ. Ghai RD, et al. Res Commun Mol Pathol Pharmacol. 1995 Feb;87(2):211-20. Res Commun Mol Pathol Pharmacol. 1995. PMID: 7749658

6

Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme.

De Lombaert S, Ghai RD, Jeng AY, Trapani AJ, Webb RL. De Lombaert S, et al. Among authors: ghai rd. Biochem Biophys Res Commun. 1994 Oct 14;204(1):407-12. doi: 10.1006/bbrc.1994.2473. Biochem Biophys Res Commun. 1994. PMID: 7945387

7

Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.

Kukkola PJ, Savage P, Sakane Y, Berry JC, Bilci NA, Ghai RD, Jeng AY. Kukkola PJ, et al. Among authors: ghai rd. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S65-8. J Cardiovasc Pharmacol. 1995. PMID: 8587470

8

Dicarboxylic acid dipeptide neutral endopeptidase inhibitors.

Ksander GM, Ghai RD, deJesus R, Diefenbacher CG, Yuan A, Berry C, Sakane Y, Trapani A. Ksander GM, et al. Among authors: ghai rd. J Med Chem. 1995 May 12;38(10):1689-700. doi: 10.1021/jm00010a014. J Med Chem. 1995. PMID: 7752193

9

Design and synthesis of an orally active macrocyclic neutral endopeptidase 24.11 inhibitor.

MacPherson LJ, Bayburt EK, Capparelli MP, Bohacek RS, Clarke FH, Ghai RD, Sakane Y, Berry CJ, Peppard JV, Trapani AJ. MacPherson LJ, et al. Among authors: ghai rd. J Med Chem. 1993 Nov 26;36(24):3821-8. doi: 10.1021/jm00076a009. J Med Chem. 1993. PMID: 8254611

10

Heterocyclic lactam derivatives as dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibitors.

Stanton JL, Sperbeck DM, Trapani AJ, Cote D, Sakane Y, Berry CJ, Ghai RD. Stanton JL, et al. Among authors: ghai rd. J Med Chem. 1993 Nov 26;36(24):3829-33. doi: 10.1021/jm00076a010. J Med Chem. 1993. PMID: 8254612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters